1-2 of 2
Marie Chammas, BSc
Close
Sort by
Journal Articles

Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates

Jennifer Whangbo, MD PhD, Haesook T Kim, PhD, Jeremy Stewart, BA, Lauren Leonard, BSc, Soomin Kim, BA, Carol Reynolds, PhD, Marie Chammas, BSc, Kelly Verrill, BSN, Michelle A. Lee, MD PhD, Steven P. Margossian, MD PhD, Christine Duncan, MD MSc, Leslie E. Lehmann, MD, Sarah Nikiforow, MD PhD, Edwin Alyea, MD, Philippe Armand, MD PhD, Corey Cutler, MD MPH, FRCPC, Vincent T Ho, MD, Bruce Blazar, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Robert J. Soiffer, MD, John Koreth, MBBS, DPhil
Journal: Blood
Blood (2017) 130 (Supplement 1): 3248.
https://doi.org/10.1182/blood.V130.Suppl_1.3248.3248
Published: 2017
Journal Articles

Phase I Trial of Regulatory T-Cell Donor Lymphocyte Infusion Plus Daily Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Versus-Host Disease

Sarah Nikiforow, MD PhD, Haesook T Kim, PhD, Kyle T Jones, Jeremy Stewart, BA, Heather Garrity, Heather Daley, Shanna Richard, Renee Manduke, Marie Chammas, BSc, Carol Reynolds, PhD, Andrew Burden, Jennifer Whangbo, MD PhD, Bruce Blazar, MD, Philippe Armand, MD PhD, Vincent T Ho, MD, Edwin Alyea, MD, Corey Cutler, MD MPH, FRCPC, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, John Koreth, MBBS, DPhil
Journal: Blood
Blood (2017) 130 (Supplement 1): 511.
https://doi.org/10.1182/blood.V130.Suppl_1.511.511
Published: 2017